Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia modelsLisa Crawford, A E Irvine|Oncogenesis|2014Cited by 26